FDA — authorised 30 August 1984
- Application: NDA018631
- Marketing authorisation holder: VALIDUS PHARMS
- Local brand name: TRENTAL
- Indication: TABLET, EXTENDED RELEASE — ORAL
- Status: approved
FDA authorised pentoxifylline (PTX) on 30 August 1984
Yes. FDA authorised it on 30 August 1984.
VALIDUS PHARMS holds the US marketing authorisation.